Today’s episode is a bit different — different in that we are rejoined by a previous guest — David Mittelman. David is CEO of Othram, the first genomics-based forensics company. The audience response to our first conversation was so overwhelming we wanted to have David back on. And the timing couldn’t be better. Since our last chat, David and Othram have been all over the news, and have launched a new database product.
Visit TPM E18 for highlights and links from this episode.
Talking Precision Medicine